We here also detected activation of the UPR in AD cases, although this appeared to be selective for p-PERK levels, which correlated with Braak stages, NIA-AA classifications, Thal phase and some measures of cognitive decline. This evidence concerns the gene EIF2AK3 and Alzheimer disease.